JP2011516477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516477A5 JP2011516477A5 JP2011502992A JP2011502992A JP2011516477A5 JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5 JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- dry eye
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 4
- 206010013774 Dry eye Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 102000015728 Mucins Human genes 0.000 claims 2
- 108010063954 Mucins Proteins 0.000 claims 2
- 150000001923 cyclic compounds Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000816 peptidomimetic Substances 0.000 claims 2
- 230000028327 secretion Effects 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12303608P | 2008-04-04 | 2008-04-04 | |
| US61/123,036 | 2008-04-04 | ||
| US20887309P | 2009-02-27 | 2009-02-27 | |
| US61/208,873 | 2009-02-27 | ||
| PCT/US2009/002121 WO2009123761A1 (en) | 2008-04-04 | 2009-04-03 | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025563A Division JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011516477A JP2011516477A (ja) | 2011-05-26 |
| JP2011516477A5 true JP2011516477A5 (enExample) | 2012-05-24 |
| JP5480242B2 JP5480242B2 (ja) | 2014-04-23 |
Family
ID=40897413
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011502992A Active JP5480242B2 (ja) | 2008-04-04 | 2009-04-03 | ドライアイ治療用βターンペプチド模倣環式化合物 |
| JP2014025563A Active JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025563A Active JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US8293713B2 (enExample) |
| EP (1) | EP2271337B1 (enExample) |
| JP (2) | JP5480242B2 (enExample) |
| KR (1) | KR101565185B1 (enExample) |
| CN (1) | CN102046166B (enExample) |
| AU (1) | AU2009232352B2 (enExample) |
| CA (1) | CA2720141C (enExample) |
| ES (1) | ES2521515T3 (enExample) |
| WO (1) | WO2009123761A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009232352B2 (en) * | 2008-04-04 | 2013-09-05 | Mimetogen Pharmaceuticals Inc. | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| JP6248103B2 (ja) * | 2012-06-22 | 2017-12-13 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | β−ターン環式ペプチド模倣化合物の合成 |
| KR20150004652A (ko) | 2013-07-03 | 2015-01-13 | 삼성디스플레이 주식회사 | 표시 패널, 이를 포함하는 표시 장치 및 이를 이용하는 영상 표시 방법 |
| JP6267003B2 (ja) * | 2014-02-27 | 2018-01-24 | 参天製薬株式会社 | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 |
| KR101984116B1 (ko) | 2015-01-12 | 2019-05-31 | 켄달리온 테라퓨틱스 인코포레이티드 | 마이크로-액적 전달 장치 및 방법 |
| WO2016164830A1 (en) | 2015-04-10 | 2016-10-13 | Lagunita Llc | Piezoelectric dispenser with replaceable ampoule |
| CN114874288A (zh) | 2015-07-09 | 2022-08-09 | 米梅奥亨制药公司 | β-转角环状模拟肽盐的溶液相合成和结晶 |
| KR101718733B1 (ko) | 2015-08-21 | 2017-03-22 | 국제약품 주식회사 | 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제 |
| JP2019507193A (ja) | 2016-03-04 | 2019-03-14 | ジェームズ・エム・ライナーソン | 細菌のバイオフィルム形成を阻止又は妨害することによって眼障害を治療する方法 |
| CA3039106A1 (en) | 2017-01-20 | 2018-07-26 | Kedalion Therapeutics, Inc. | Piezoelectric fluid dispenser |
| JP7436363B2 (ja) | 2017-12-08 | 2024-02-21 | ノバルティス アーゲー | 流体送達アライメントシステム |
| CN110092799B (zh) * | 2018-01-29 | 2021-11-12 | 广州丹康医药生物有限公司 | 一种环状化合物、其制备方法和应用 |
| US20190314197A1 (en) | 2018-04-12 | 2019-10-17 | Kedalion Therapeutics, Inc. | Topical Ocular Delivery Methods and Devices for Use in the Same |
| US12350194B1 (en) | 2018-04-12 | 2025-07-08 | Bausch + Lomb Ireland Limited | Topical ocular delivery of fluids with controlled mass dosing and wireless communication |
| CA3102410A1 (en) | 2018-07-03 | 2020-01-09 | Kedalion Therapeutics, Inc. | Topical ocular delivery devices and methods for using the same |
| US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
| US12097145B2 (en) | 2019-03-06 | 2024-09-24 | Bausch + Lomb Ireland Limited | Vented multi-dose ocular fluid delivery system |
| US12496218B1 (en) | 2019-11-12 | 2025-12-16 | Bausch + Lomb Ireland Limited | Fractionated topical ocular drug delivery methods and devices for use in the same |
| US11938057B2 (en) | 2020-04-17 | 2024-03-26 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| WO2021212038A1 (en) | 2020-04-17 | 2021-10-21 | Kedalion Therapeutics, Inc. | Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir |
| US12290472B2 (en) | 2020-04-17 | 2025-05-06 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| JP7711090B2 (ja) | 2020-04-17 | 2025-07-22 | ボシュ ＋ ロム アイルランド リミテッド | 流体力学的に起動される防腐剤無添加分注システム |
| IL308909A (en) * | 2021-06-02 | 2024-01-01 | The Texas A& M Univ System | Selective small molecule agonists and partial agonists of TRK receptors |
| WO2023069255A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| EP4419123A1 (en) * | 2021-10-20 | 2024-08-28 | Stealth BioTherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917217D0 (en) * | 1989-07-27 | 1989-09-13 | Smith & Nephew | Ophthalmic compositions |
| US5545617A (en) * | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| KR20010033484A (ko) * | 1997-12-22 | 2001-04-25 | 휴먼 게놈 사이언시즈, 인크. | 각질세포 성장 인자-2 제제 |
| JP2001064198A (ja) | 1999-08-24 | 2001-03-13 | Teika Seiyaku Kk | 角膜疾患治療剤 |
| WO2001052843A1 (en) * | 2000-01-18 | 2001-07-26 | Mcgill University | β-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS |
| EP1734052B1 (en) * | 2005-06-13 | 2009-02-18 | Primm S.R.L. | Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders |
| EP1921087A1 (en) | 2006-11-10 | 2008-05-14 | Primm S.R.L. | Process for the preparation of cyclic peptides |
| AU2007327990A1 (en) | 2006-12-05 | 2008-06-12 | The Royal Institution For The Advancement Of Learning/ Mcgill University | Methods of use of TRK receptor modulators |
| AU2009232352B2 (en) * | 2008-04-04 | 2013-09-05 | Mimetogen Pharmaceuticals Inc. | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| WO2010099436A1 (en) * | 2009-02-27 | 2010-09-02 | Mimetogen Pharmaceuticals, Inc. | Methods of treating retinitis pigmentosa |
| JP6248103B2 (ja) * | 2012-06-22 | 2017-12-13 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | β−ターン環式ペプチド模倣化合物の合成 |
-
2009
- 2009-04-03 AU AU2009232352A patent/AU2009232352B2/en active Active
- 2009-04-03 CA CA2720141A patent/CA2720141C/en active Active
- 2009-04-03 US US12/935,217 patent/US8293713B2/en active Active
- 2009-04-03 ES ES09726969.0T patent/ES2521515T3/es active Active
- 2009-04-03 WO PCT/US2009/002121 patent/WO2009123761A1/en not_active Ceased
- 2009-04-03 JP JP2011502992A patent/JP5480242B2/ja active Active
- 2009-04-03 KR KR1020107024714A patent/KR101565185B1/ko active Active
- 2009-04-03 EP EP09726969.0A patent/EP2271337B1/en active Active
- 2009-04-03 CN CN2009801190689A patent/CN102046166B/zh active Active
-
2012
- 2012-08-31 US US13/601,258 patent/US8748391B2/en active Active
-
2014
- 2014-02-13 JP JP2014025563A patent/JP5870348B2/ja active Active
- 2014-05-29 US US14/290,845 patent/US9156882B2/en active Active
-
2015
- 2015-09-18 US US14/858,874 patent/US9707267B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2013525444A5 (enExample) | ||
| JP2013520405A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| EA201490774A1 (ru) | Новые производные оксазина и их применение при лечении заболевания | |
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| JP2012255026A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| RU2014120792A (ru) | Способ лечения стромальных опухолей желудочно-кишечного тракта | |
| NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
| UA104489C2 (uk) | Сполуки для лікування дисліпідемії та споріднених хвороб | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| MX339614B (es) | Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2. | |
| RU2017139870A (ru) | Новые агонисты npr-b | |
| RU2017114352A (ru) | АНТАГОНИСТЫ ИНТЕГРИНА ανβ6 | |
| JP2013531028A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| MX350195B (es) | Analogos de cistamina para el tratamiento de la enfermedad de parkinson. | |
| JP2012508256A5 (enExample) | ||
| JP2018532806A5 (enExample) | ||
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| JP2011046708A5 (enExample) | ||
| EA201270653A1 (ru) | Антагонист dpи его применение | |
| JP2013523739A5 (enExample) |